Johnson & Johnson (JNJ) To Pay $1B For Defective Hip Implants

A jury made the ruling against JNJ, citing that it had failed to tell doctors and patients of the potential risk of failure of its devices. This will more than likely paint a bad image for JNJ in hip replacement.